{"slideshow_credits": null, "snippet": "Eli Lilly officials said they remained hopeful that the experimental drug, which failed to stop progress of the disease in previous studies, could help patients with mild Alzheimer\u2019s disease.", "abstract": "Eli Lilly & Co says it plans an additional study of experimental Alzheimer's drug that failed to improve the condition of people with disease, saying it remains hopeful about drug's prospects.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/12/13/business/eli-lilly-to-conduct-additional-study-of-alzheimers-drug.html", "lead_paragraph": "Eli Lilly officials said they remained hopeful that the experimental drug, which failed to stop progress of the disease in previous studies, could help patients with mild Alzheimer\u2019s disease.", "headline": {"seo": "Eli Lilly to Conduct Additional Study of Alzheimer&#8217;s Drug", "main": "Experimental Alzheimer&#8217;s Drug Will Get More Study at Eli Lilly", "print_headline": "Experimental Alzheimer\u2019s Drug Will Get More Study at Eli Lilly"}, "_id": "50c8b6b900315214fbb7f1b2", "word_count": "296", "multimedia": [], "pub_date": "2012-12-13T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Alzheimer's Disease", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Eli Lilly and Company", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}